Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 8
1947 9
1948 2
1949 1
1950 1
1951 1
1952 2
1953 2
1954 3
1965 1
1967 1
1970 1
1971 5
1973 3
1974 2
1975 1
1976 1
1977 3
1978 4
1979 1
1980 1
1981 1
1982 2
1983 1
1984 1
1986 1
1988 1
1989 3
1990 1
1991 1
1992 1
1993 2
1994 3
1995 1
1996 5
1997 2
1998 2
2000 1
2001 4
2002 6
2003 5
2004 4
2005 5
2006 12
2007 8
2008 6
2009 8
2010 6
2011 8
2012 23
2013 12
2014 18
2015 16
2016 14
2017 12
2018 14
2019 7
2020 20
2021 27
2022 23
2023 12
2024 13
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

343 results

Results by year

Filters applied: . Clear all
Page 1
The 2023 nonhormone therapy position statement of The North American Menopause Society.
“The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. “The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. Menopause. 2023 Jun 1;30(6):573-590. doi: 10.1097/GME.0000000000002200. Menopause. 2023. PMID: 37252752 Review.
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.
Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, Solomon SD, Marler JR, Teerlink JR, Farb A, Morrow DA, Targum SL, Sila CA, Hai MTT, Jaff MR, Joffe HV, Cutlip DE, Desai AS, Lewis EF, Gibson CM, Landray MJ, Lincoff AM, White CJ, Brooks SS, Rosenfield K, Domanski MJ, Lansky AJ, McMurray JJV, Tcheng JE, Steinhubl SR, Burton P, Mauri L, O'Connor CM, Pfeffer MA, Hung HMJ, Stockbridge NL, Chaitman BR, Temple RJ; Standardized Data Collection for Cardiovascular Trials Initiative (SCTI). Hicks KA, et al. Among authors: joffe hv. Circulation. 2018 Feb 27;137(9):961-972. doi: 10.1161/CIRCULATIONAHA.117.033502. Circulation. 2018. PMID: 29483172 Review.
Duration of menopausal vasomotor symptoms over the menopause transition.
Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, Hess R, Joffe H, Kravitz HM, Tepper PG, Thurston RC; Study of Women's Health Across the Nation. Avis NE, et al. Among authors: joffe h. JAMA Intern Med. 2015 Apr;175(4):531-9. doi: 10.1001/jamainternmed.2014.8063. JAMA Intern Med. 2015. PMID: 25686030 Free PMC article.
Promoting good mental health over the menopause transition.
Brown L, Hunter MS, Chen R, Crandall CJ, Gordon JL, Mishra GD, Rother V, Joffe H, Hickey M. Brown L, et al. Among authors: joffe h. Lancet. 2024 Mar 9;403(10430):969-983. doi: 10.1016/S0140-6736(23)02801-5. Epub 2024 Mar 5. Lancet. 2024. PMID: 38458216 Review.
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1).
Simon JA, Anderson RA, Ballantyne E, Bolognese J, Caetano C, Joffe H, Kerr M, Panay N, Seitz C, Seymore S, Trower M, Zuurman L, Pawsey S. Simon JA, et al. Among authors: joffe h. Menopause. 2023 Mar 1;30(3):239-246. doi: 10.1097/GME.0000000000002138. Epub 2023 Jan 30. Menopause. 2023. PMID: 36720081 Free PMC article. Clinical Trial.
343 results